News
59m
News-Medical.Net on MSNWhat’s behind Gen Z’s skepticism about Ozempic and WegovyA U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...
A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results